Clinical Trial Update: Safety and Feasibility Study of the MitraFix® Transcatheter Mitral Valve System [NA]

View source ↗

Summary

A clinical trial update indicates the MitraFix Transcatheter Mitral Valve System safety and feasibility study for mitral regurgitation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Drugs mentioned

• MitraFix Transcatheter Mitral Valve System

Snippet

Sponsor: Mitrassist Lifesciences Limited Co., Ltd. | Conditions: Mitral Regurgitation (MR) | NA | Status: RECRUITING